344 related articles for article (PubMed ID: 33854480)
1. Thrombospondin 1 in Metabolic Diseases.
Gutierrez LS; Gutierrez J
Front Endocrinol (Lausanne); 2021; 12():638536. PubMed ID: 33854480
[TBL] [Abstract][Full Text] [Related]
2. CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis.
Singla B; Aithbathula RV; Pervaiz N; Kathuria I; Swanson M; Ekuban FA; Ahn W; Park F; Gyamfi M; Cherian-Shaw M; Singh UP; Kumar S
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1234-1250. PubMed ID: 37259865
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
4. CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes.
Roberts DD; Isenberg JS
Am J Physiol Cell Physiol; 2021 Aug; 321(2):C201-C213. PubMed ID: 34106789
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata.
Erdem N; Chen KT; Qi M; Zhao Y; Wu X; Garcia I; Ku HT; Montero E; Al-Abdullah IH; Kandeel F; Roep BO; Isenberg JS
Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E347-E357. PubMed ID: 36791324
[TBL] [Abstract][Full Text] [Related]
6. Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.
Rogers NM; Ghimire K; Calzada MJ; Isenberg JS
Cardiovasc Res; 2017 Jul; 113(8):858-868. PubMed ID: 28472457
[TBL] [Abstract][Full Text] [Related]
7. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
8. TSP1 ameliorates age-related macular degeneration by regulating the STAT3-iNOS signaling pathway.
Li J; He J; Zhang X; Li J; Zhao P; Fei P
Exp Cell Res; 2020 Mar; 388(1):111811. PubMed ID: 31899207
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-specific deletion of thrombospondin 1 protects against inflammation and insulin resistance in long-term diet-induced obese male mice.
Memetimin H; Li D; Tan K; Zhou C; Liang Y; Wu Y; Wang S
Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1194-E1203. PubMed ID: 30351986
[TBL] [Abstract][Full Text] [Related]
10. Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.
Cui W; Maimaitiyiming H; Zhou Q; Norman H; Zhou C; Wang S
Biochim Biophys Acta; 2015 Jul; 1852(7):1323-33. PubMed ID: 25835637
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
Kaur S; Martin-Manso G; Pendrak ML; Garfield SH; Isenberg JS; Roberts DD
J Biol Chem; 2010 Dec; 285(50):38923-32. PubMed ID: 20923780
[TBL] [Abstract][Full Text] [Related]
12. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
Isenberg JS; Pappan LK; Romeo MJ; Abu-Asab M; Tsokos M; Wink DA; Frazier WA; Roberts DD
Ann Surg; 2008 Jan; 247(1):180-90. PubMed ID: 18156939
[TBL] [Abstract][Full Text] [Related]
13. Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
Stirling ER; Terabe M; Wilson AS; Kooshki M; Yamaleyeva LM; Alexander-Miller MA; Zhang W; Miller LD; Triozzi PL; Soto-Pantoja DR
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36418073
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.
Rogers NM; Sharifi-Sanjani M; Csányi G; Pagano PJ; Isenberg JS
Matrix Biol; 2014 Jul; 37():92-101. PubMed ID: 24418252
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells.
Wang S; Shiva S; Poczatek MH; Darley-Usmar V; Murphy-Ullrich JE
J Biol Chem; 2002 Mar; 277(12):9880-8. PubMed ID: 11784717
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Regulation of Thrombospondins and Its Functional Validation through CRISPR/Cas9 Mediated Gene Editing in Corpus Luteum of Water Buffalo (Bubalus Bubalis).
Paul A; Bharati J; Punetha M; Kumar S; Mallesh VG; Chouhan VS; Sonwane A; Bag S; Bhure SK; Maurya VP; Singh G; Whitworth KM; Sarkar M
Cell Physiol Biochem; 2019; 52(3):532-552. PubMed ID: 30897320
[TBL] [Abstract][Full Text] [Related]
18. Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.
Rogers NM; Roberts DD; Isenberg JS
Ann Surg; 2013 Jul; 258(1):184-91. PubMed ID: 23275312
[TBL] [Abstract][Full Text] [Related]
19. Expression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells.
Fei P; Zaitoun I; Farnoodian M; Fisk DL; Wang S; Sorenson CM; Sheibani N
PLoS One; 2014; 9(12):e116423. PubMed ID: 25548916
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells.
Gao Q; Chen K; Gao L; Zheng Y; Yang YG
Cell Death Dis; 2016 Sep; 7(9):e2368. PubMed ID: 27607583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
